摘要:
A transmitting node produces synchronization data to be inserted into plain text and encrypts the thus generated data into multi-valued data so as to transmit the data. The synchronization data indicates the position of a running key used for encryption. A receiving node decrypts a signal including the synchronization data using the running key and detects the synchronization data from the signal to confirm synchronization of the running key between transmitting and receiving nodes. Then, the receiving node transmits a synchronization confirmation signal to the transmitting node. If the transmitting node does not receive the synchronization confirmation signal, it determines that the synchronization of the running key is shifted, and re-synchronization is performed. To perform re-synchronization, a running key ahead of the position of the running key associated with synchronization data that has been stored is generated.
摘要:
The present invention provides a polypeptide selected from the following (A), (B) and (C), having a function or an activity as a receptor of an eicosanoid (5-oxo-ETE, etc.); (A) a polypeptide comprising an amino acid sequence shown by SEQ ID NO:2 or SEQ ID NO:21; (B) a polypeptide comprising an amino acid sequence shown by SEQ ID NO: 2 or SEQ.ID.NO:21 in which one or several amino acids are deleted, substituted or added; (C) a polypeptide encoded by a nucleic acid which hybridizes under stringent condition with a nucleic acid comprising a nucleotide sequence shown by SEQ ID NO:1 or SEQ ID NO:20 or a complement thereof, a nucleic acid encoding the polypeptide, a recombinant vector and a host cell comprising the same, a method for detecting a function or an activity of the polypeptide using the same, and a method for screening or identifying a ligand or an effector (an agonist or an antagonist) of the polypeptide using the same, a pharmaceutical composition comprising an antagonist of the polypeptide, and a therapeutic method using the antagonist, etc.
摘要翻译:本发明提供具有作为类花生酸(5-氧代-ETE等)的受体的功能或活性的选自以下(A),(B)和(C)的多肽; (A)包含SEQ ID NO:2或SEQ ID NO:21所示的氨基酸序列的多肽; (B)包含SEQ ID NO:2或SEQ.ID.NO:21所示的氨基酸序列的多肽,其中一个或几个氨基酸被缺失,取代或加入; (C)由在严格条件下与包含SEQ ID NO:1或SEQ ID NO:20所示核苷酸序列的核酸或其互补序列的核酸编码的多肽,编码该多肽的核酸,重组体 载体和包含其的宿主细胞,使用其的多肽的功能或活性的检测方法,以及使用该多肽的多肽的配体或效应子(激动剂或拮抗剂)的筛选或鉴定的方法 ,包含多肽的拮抗剂的药物组合物和使用拮抗剂的治疗方法等
摘要:
The disclosed is a method for synchronization of the running key that is generated from a shared key and that is used for encryption and decryption in communications encrypted with the shared key using a multi-valued signal. In the method for synchronization, the transmitting node transmits a signal that is formed of a multi-valued signal and that has a predetermined fixed pattern before transmitting data encrypted with the shared key. The receiving node generates a bit discrimination threshold signal that allows for bit discrimination and that has a fixed length, shifts bit by bit the phase of the bit discrimination threshold signal while monitoring bit discrimination with respect to a fixed pattern signal that is to be received, and sets the phase of the bit discrimination threshold signal when the phase of the fixed pattern signal matches the phase of the bit discrimination threshold signal. Then, synchronization of the running key is performed in accordance with the phase that has been set between the transmitting node and the receiving node.
摘要:
The present invention provides a polypeptide selected from the following (A), (B) and (C), having a function or an activity as a receptor of an eicosanoid (5-oxo-ETE, etc.); (A) a polypeptide comprising an amino acid sequence shown by SEQ ID NO:2 or SEQ ID NO:21; (B) a polypeptide comprising an amino acid sequence shown by SEQ ID NO: 2 or SEQ.ID.NO:21 in which one or several amino acids are deleted, substituted or added; (C) a polypeptide encoded by a nucleic acid which hybridizes under stringent condition with a nucleic acid comprising a nucleotide sequence shown by SEQ ID NO:1 or SEQ ID NO:20 or a complement thereof, a nucleic acid encoding the polypeptide, a recombinant vector and a host cell comprising the same, a method for detecting a function or an activity of the polypeptide using the same, and a method for screening or identifying a ligand or an effector (an agonist or an antagonist) of the polypeptide using the same, a pharmaceutical composition comprising an antagonist of the polypeptide, and a therapeutic method using the antagonist, etc.
摘要翻译:本发明提供具有作为类花生酸(5-氧代-ETE等)的受体的功能或活性的选自以下(A),(B)和(C)的多肽; (A)包含SEQ ID NO:2或SEQ ID NO:21所示的氨基酸序列的多肽; (B)包含SEQ ID NO:2或SEQ.ID.NO:21所示的氨基酸序列的多肽,其中一个或几个氨基酸被缺失,取代或加入; (C)由在严格条件下与包含SEQ ID NO:1或SEQ ID NO:20所示核苷酸序列的核酸或其互补序列的核酸编码的多肽,编码该多肽的核酸,重组体 载体和包含其的宿主细胞,使用其的多肽的功能或活性的检测方法,以及使用该多肽的多肽的配体或效应子(激动剂或拮抗剂)的筛选或鉴定的方法 ,包含多肽的拮抗剂的药物组合物和使用拮抗剂的治疗方法等
摘要:
A transmitting node produces synchronization data to be inserted into plain text and encrypts the thus generated data into multi-valued data so as to transmit the data. The synchronization data indicates the position of a running key used for encryption. A receiving node decrypts a signal including the synchronization data using the running key and detects the synchronization data from the signal to confirm synchronization of the running key between transmitting and receiving nodes. Then, the receiving node transmits a synchronization confirmation signal to the transmitting node. If the transmitting node does not receive the synchronization confirmation signal, it determines that synchronization of the running key is shifted, and re-synchronization is performed. To perform re-synchronization, a running key ahead of the position of the running key associated with synchronization data that has been stored is generated.
摘要:
The disclosed is a method for synchronization of the running key that is generated from a shared key and that is used for encryption and decryption in communications encrypted with the shared key using a multi-valued signal. In the method for synchronization, the transmitting node transmits a signal that is formed of a multi-valued signal and that has a predetermined fixed pattern before transmitting data encrypted with the shared key. The receiving node generates a bit discrimination threshold signal that allows for bit discrimination and that has a fixed length, shifts bit by bit the phase of the bit discrimination threshold signal while monitoring bit discrimination with respect to a fixed pattern signal that is to be received, and sets the phase of the bit discrimination threshold signal when the phase of the fixed pattern signal matches the phase of the bit discrimination threshold signal. Then, synchronization of the running key is performed in accordance with the phase that has been set between the transmitting node and the receiving node.